Membrane proteins Archives - Inside Precision Medicine

Molecular Dx

Scientists Discover Cancer Protein Enhancing Anti-Tumoral Immune Response

Alisa Kirkin -

September 15, 2023

T-cell background

News & Features

Mechanism Revealed of How Gamma Delta T Cells Recognize Cancer

Chris Anderson -

September 6, 2023

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room.

News & Features

Novo Nordisk Acquires Obesity Drug Developer Inversago for up to $1.075B

Malorye Branca -

August 11, 2023

Opioid pain medication

News & Features

New Target for Addiction-Free Pain Treatment Found

Chris Anderson -

May 3, 2023

Abstract Molecular structure

Molecular Dx

Liquid Biopsy: How to Embrace Perfection?

Kathy Vuksanaj -

June 15, 2022

News & Features

Gene Responsible for Group of Rare Immune Diseases Potentially Identified

Kathy Vuksanaj -

February 28, 2020

Biocept will evaluate the clinical utility and cost effectiveness of using Biocept's Target Selector testing in patients diagnosed with non-small cell lung cancer (NSCLC)

Molecular Dx

Biocept to Study Clinical Utility, Cost Effectiveness of Assays in NSCLC Patients

Clinical OMICs Staff Writer -

August 6, 2018

Related Content

Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone Treatments

Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone Treatments

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer

Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer

Low-Dose Radiation Therapy Unveiled as Potential Treatment for Heart Failure

Low-Dose Radiation Therapy Unveiled as Potential Treatment for Heart Failure